Current therapies for medulloblastoma were introduced primarily in the 1980s and consist of
predominantly cytotoxic, nontargeted approaches. Mortality from medulloblastoma remains …

Brain tumors are the leading cause of cancer-related death in children, and
medulloblastoma (MB) is the most common malignant pediatric brain tumor. Advances in …

Background Medulloblastoma in adult patients is rare, with 0.6 cases per million. Prognosis
depends on clinical factors and medulloblastoma entity. No prospective data on the …

Simple Summary Patients with medulloblastoma receive treatment according to a risk
stratification, which is a combination of clinical and biological factors. To date there have …

Background Although the majority of current medulloblastoma adjuvant therapy protocols
treat patients with≥ 1.5 cm 2 residual tumor as high risk with increased craniospinal …

While in adults most intracranial tumors develop around the cerebral hemispheres, 45 to
60% of pediatric lesions are found in the posterior fossa, although this anatomical region …

Medulloblastoma is the most common malignant brain tumors in children. Current
management combines surgery, radiotherapy, and chemotherapy. Current treatment of …

The management of medulloblastoma in children has dramatically changed over the past
four decades, with the development of chemotherapy protocols aiming at improving survival …

Introduction Treatment of children with medulloblastoma (MB) includes surgery, radiation
therapy (RT) and chemotherapy (CT). Several treatment protocols and clinical trials have …

We report a retrospective case series of six Hispanic children with tumors treated with
metronomic chemotherapy. The six cases comprised one rhabdoid tumor of the kidney, one …